Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04732728 · ClinicalTrials.gov registry record
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 727
- Enrollment target
NCT04732728 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 727 participants.
The verdict
NCT04732728 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 727 participants
- Enrollment target
Study Summary
The LUX-Dx PERFORM Study had two primary objects which were (1) to characterize, in a general patient population, the utilization of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor (ICM) device and (2) to collect data to characterize the performance of arrhythmia detection algorithms. Data was also collected to characterize the ICM system related safety events.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 727 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2023-05-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04732728
The ClinicalTrials.gov registry entry for NCT04732728 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 727 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04732728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04732728 about?
NCT04732728 is a clinical study titled "LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study". The LUX-Dx PERFORM Study had two primary objects which were (1) to characterize, in a general patient population, the utilization of the remote programming feature of the Boston Scientific (BSC) Insertable Cardiac Monitor (ICM) device and (2) to collect data to characterize the performance of arrhyt...
What is the current status of trial NCT04732728?
This trial is currently completed. The enrollment target is 727 participants. The study started on 2021-03-05. Estimated completion is 2023-05-18.
Who is sponsoring clinical trial NCT04732728?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.